Sign In
Buy HIMS
$27.51
+0 (+0%)
At Close: Jun 03, 2026
Is Hims & Hers Health Stock a Buy?
04:20am, Tuesday, 10'th Sep 2024
Hims & Hers stock price has plummeted in recent weeks. Share prices no longer reflect GLP-1 hype.
Hims & Hers Stock Plunges 32.1% in Three Months: What's Next?
01:06pm, Thursday, 05'th Sep 2024
HIMS is enhancing its offerings and expanding the breadth of health and wellness products and services. However, macro challenges are likely to hurt its performance.
Got $1,000? 3 Healthcare Stocks to Buy and Hold Forever
04:50am, Thursday, 05'th Sep 2024
Hims & Hers is rapidly picking up steam in the telehealth industry. UnitedHealth's dominance has created massive wealth for long-term investors.
The Big 3: HIMS, TLT & WFC
01:26pm, Wednesday, 04'th Sep 2024
Ben Lichtenstein and Don Kaufman focus on finance and health in today's Big 3. They break down the technical trends for Hims & Hers (HIMS), the iShares 20+ Year Treasury Bond (TLT), and Wells Fargo (W
Has Eli Lilly Destroyed Hims & Hers Upside?
04:37pm, Tuesday, 03'rd Sep 2024
Capitalizing on the popularity of weight-loss drugs like Wegovy and Zepbound, Hims & Hers Health (NYSE:HIMS) has exploited a loophole in Food & Drug Administration regulations to bring to market simil
Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know
10:01am, Monday, 02'nd Sep 2024
Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine what the stock has in store.
Billionaires Are Buying Hims & Hers Health Hand Over Fist. Should You Follow Their Lead?
03:57am, Sunday, 01'st Sep 2024
Funds run by Israel Englander, John Overdeck, and David Siegel bought more than a million shares of Hims & Hers Health in the second quarter. Hims & Hers Health runs a niche telehealth service for peo
2 No-Brainer Growth Stocks to Buy With $200 Right Now
04:15pm, Saturday, 31'st Aug 2024
Both companies revolve around subscription-based services. Hims & Hers is witnessing high-double-digit growth, and profits are soaring.
Why Hims & Hers Health Stock Was Falling This Week
09:52pm, Thursday, 29'th Aug 2024
Eli Lilly is discounting Zepbound, potentially undercutting a growing business for Hims & Hers. Pharma companies are starting to sell more drugs direct-to-consumer, threatening traditional pharmacies.
Is Hims & Hers Health Stock a Buy?
04:30am, Thursday, 29'th Aug 2024
Hims & Hers has carved a strong niche in the men's healthcare segment while expanding into other areas. The weight-loss category is a huge opportunity for the company.
Why Hims & Hers Stock Crashed on Tuesday
04:45pm, Tuesday, 27'th Aug 2024
Eli Lilly's Zepbound got a 50% price cut that could take some of Hims & Hers growth potential. Lower-cost drugs could be good news for Hims & Hers long term.
Hims & Hers Health Stock Takes Hit as Eli Lilly Offers Cheaper Weight-Loss Drug
12:21pm, Tuesday, 27'th Aug 2024
Shares of Hims & Hers Health (HIMS) sank in intraday trading Tuesday on new competition for lower-priced weight-loss drugs from Eli Lilly (LLY).
Eli Lilly Is Offering a Cheaper Form of Zepbound. What It Means for Hims & Hers Stock.
08:44am, Tuesday, 27'th Aug 2024
The new option is priced at a 50% or more discount compared to other weight-loss drugs.
What Is Going On With Hims & Hers Stock?
11:54am, Thursday, 22'nd Aug 2024
After a strong start to the year, the stock is down 30% since June.
Hims & Hers Health: GLP-1 Is Not The Only Tailwind In This Growth Story
11:20pm, Tuesday, 20'th Aug 2024
Hims & Hers Health stock is up over 37% since my initial coverage, as the company is experiencing strong investor optimism from its compounded GLP-1 additions to its Weight Loss portfolio. The company
